Clemens Fischer
Chairman bei PHARMASGP HOLDING SE
Profil
Clemens Fischer is the founder of PharmaSGP GmbH and Futrue GmbH, established in 2009 and 2007, respectively.
He is currently the Chairman-Supervisory Board at PharmaSGP Holding SE since 2020.
Previously, he worked as the Head-Cardiovascular & Metabolic Business Unit at Novartis Pharma Germany from 2006 to 2008 and as the Senior Manager-Transplantation & Immunology at Novartis Pharma Germany from 2002 to 2003.
Dr. Fischer holds undergraduate, graduate, and doctorate degrees from Technische Universität München and an MBA degree from Harvard Business School.
Aktive Positionen von Clemens Fischer
| Unternehmen | Position | Beginn |
|---|---|---|
| PHARMASGP HOLDING SE | Chairman | 04.03.2020 |
PharmaSGP GmbH
 PharmaSGP GmbH Miscellaneous Commercial ServicesCommercial Services PharmaSGP GmbH focuses on the development and distribution of chemical-free drugs on pain therapy. It brands include RUBAXX® for rheumatic pain, RESTAXIL® for neuralgic pain (nerve pain) and DESEO® and NERADIN® for against sexual weakness & vertigo symptoms. The company was founded by Madlena Hohlefelder and Clemens Fischer in 2009 and is headquartered in Gräfelfing, Germany. | Founder | 01.01.2009 |
Futrue GmbH
 Futrue GmbH Pharmaceuticals: MajorHealth Technology Futrue GmbH is an international healthcare incubator with over 20 companies and more than 70 approved pharmaceutical products. Futrue is based in Graefeling, DE and was founded by Madlena Hohlefelder and Clemens Fischer. The German company focuses on smart bacteria and operates in the healthcare industry. Clemens Fischer has been the CEO since incorporation. | Chief Executive Officer | 01.01.2008 |
Ehemalige bekannte Positionen von Clemens Fischer
| Unternehmen | Position | Ende |
|---|---|---|
| Novartis Pharma Germany | Corporate Officer/Principal | 01.01.2008 |
| Novartis Pharma Germany | Corporate Officer/Principal | 01.01.2003 |
Ausbildung von Clemens Fischer
| Technische Universität München | Doctorate Degree |
| Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PHARMASGP HOLDING SE | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Novartis Pharma Germany | |
PharmaSGP GmbH
PharmaSGP GmbH Miscellaneous Commercial ServicesCommercial Services PharmaSGP GmbH focuses on the development and distribution of chemical-free drugs on pain therapy. It brands include RUBAXX® for rheumatic pain, RESTAXIL® for neuralgic pain (nerve pain) and DESEO® and NERADIN® for against sexual weakness & vertigo symptoms. The company was founded by Madlena Hohlefelder and Clemens Fischer in 2009 and is headquartered in Gräfelfing, Germany. | Commercial Services |
Futrue GmbH
Futrue GmbH Pharmaceuticals: MajorHealth Technology Futrue GmbH is an international healthcare incubator with over 20 companies and more than 70 approved pharmaceutical products. Futrue is based in Graefeling, DE and was founded by Madlena Hohlefelder and Clemens Fischer. The German company focuses on smart bacteria and operates in the healthcare industry. Clemens Fischer has been the CEO since incorporation. | Health Technology |
